BMO Capital Maintains Market Perform on Ashland, PT Raised to $61
ByAinvest
Tuesday, Sep 2, 2025 8:49 am ET1min read
ASH--
The latest earnings report for Ashland, released on August 13, 2025, showed a loss of $742 million or $16.21 per share for the third quarter of fiscal 2025. Despite the loss, adjusted earnings per share were $1.04, down from $1.49 in the prior-year quarter. Sales were down 14.9% year over year to $463 million, with declines in several segments including Life Sciences, Personal Care, and Specialty Additives [2].
BMO's decision to maintain the market perform rating is based on the company's recent performance and the analysts' expectation of a gradual recovery. The increased price target reflects the analysts' belief that Ashland's portfolio optimization actions and divestitures of lower-margin products will lead to improved financial results in the long term.
Analysts' ratings for Ashland remain mixed, with a consensus rating of "Hold" based on five recent ratings from Wall Street analysts. The consensus price target is $65.60, with a high forecast of $84.00 and a low forecast of $53.00. The average predicted upside is 20.25% based on analysts' 12-month stock forecasts [1].
Investors should monitor Ashland's upcoming earnings releases and any further developments in the company's portfolio optimization strategy to gauge the potential impact on its stock price. As always, it is essential for investors to conduct their own research and consider their individual risk tolerance and investment objectives.
References:
[1] https://www.marketbeat.com/stocks/NYSE/ASH/forecast/
[2] https://finance.yahoo.com/news/why-ashland-ash-6-7-153004611.html
BMO Capital Maintains Market Perform on Ashland, PT Raised to $61
BMO Capital Markets has maintained its market perform rating on Ashland Inc. (ASH) while increasing its price target to $61.00, according to a recent report. The new price target represents a 20.25% increase from the current stock price of $54.56, reflecting a positive outlook on the company's future performance [1].The latest earnings report for Ashland, released on August 13, 2025, showed a loss of $742 million or $16.21 per share for the third quarter of fiscal 2025. Despite the loss, adjusted earnings per share were $1.04, down from $1.49 in the prior-year quarter. Sales were down 14.9% year over year to $463 million, with declines in several segments including Life Sciences, Personal Care, and Specialty Additives [2].
BMO's decision to maintain the market perform rating is based on the company's recent performance and the analysts' expectation of a gradual recovery. The increased price target reflects the analysts' belief that Ashland's portfolio optimization actions and divestitures of lower-margin products will lead to improved financial results in the long term.
Analysts' ratings for Ashland remain mixed, with a consensus rating of "Hold" based on five recent ratings from Wall Street analysts. The consensus price target is $65.60, with a high forecast of $84.00 and a low forecast of $53.00. The average predicted upside is 20.25% based on analysts' 12-month stock forecasts [1].
Investors should monitor Ashland's upcoming earnings releases and any further developments in the company's portfolio optimization strategy to gauge the potential impact on its stock price. As always, it is essential for investors to conduct their own research and consider their individual risk tolerance and investment objectives.
References:
[1] https://www.marketbeat.com/stocks/NYSE/ASH/forecast/
[2] https://finance.yahoo.com/news/why-ashland-ash-6-7-153004611.html

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet